jun 5, 2018: 1:45 p.m. - 2:45 p.m.
Room 210B, Level 2
With so many breakthroughs in a short period of time, it is no wonder cancer is the darling of immunotherapy. From checkpoint inhibitors to game-changing T-cell therapy, cancer has been the impetus for numerous immunological advancements.
Progress has also been made in non-oncology immunotherapy in disease areas such as allergy, autoimmunity including rheumatoid arthritis, diabetes, celiac disease, and even infections. What insights can be shared from non-oncology approaches to immune modulation and vice versa? What has been learned and employed in oncology that has advanced the field? This panel will explore the valuable lessons from the pioneers focused on harnessing the body’s own immune system to eradicate disease.
Ability Level: All